Aripiprazole + IEM (Ingestible Event Marker) for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Mar 2016: Trial registered, NCT02722967

The trials

NCT02722967: Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

State
Completed
Phase
Phase 2
People
49 taking part
Started
Mar 2016
Primary completion
Sep 2016
Arms
Aripiprazole + IEM
Results
Posted on the registry
  1. 30 Mar 2016: Trial registered
  2. 23 May 2018: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.